Journals / Klimik Dergisi / 2012 / Cilt: 25 - Sayı: 3

A Crimean-Congo Hemorrhagic Fever Case in an Endemic Region in November

Endemik Bir Bölgede Kasım Ayında Görülen Kırım-Kongo Kanamalı Ateşi Olgusu

Pages
130–132
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CCHF should be considered in differential diagnosis of patients between April to November in endemic areas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Crimean-Congo hemorrhagic fever (CCHF) is an acute and serious viral disease that is transmitted by the bites of ticks and clinically manifested with fever and bleeding.
📊
Key Findings & Data:A 59-year-old male was hospitalized after a tick bite with complaints of weakness, fatigue, and generalized muscle ache was hospitalized.
💡
Conclusion & Impact:CCHF should be considered in differential diagnosis of patients between April to November in endemic areas.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is an acute and serious viral disease that is transmitted by the bites of ticks and clinically manifested with fever and bleeding. CCHF is endemic in the Central and Northern Anatolia regions of Turkey. The disease is generally seen in spring and summer. We report the first CCHF case diagnosed in November in Tokat. A 59-year-old male was hospitalized after a tick bite with complaints of weakness, fatigue, and generalized muscle ache was hospitalized. At that time, axillary temperature was 39°C, blood pressure was 110/70 mmHg, pulse rate was 86/minute, and clinical examination was unremarkable except fever. White blood cell (WBC) count was 2200/ µL, hemoglobin was 11.7 g/dL, platelet was 78 000/µL, C-reactive protein (CRP) was 7.0 mg/dL, prothrombin time (PT) was 14.7 seconds, aspartate aminotransferase (AST) was 63 IU/L, alanine aminotransferase (ALT) 42 IU/L in the laboratory examination. Due to clinical and laboratory findings, the patient suspected of having CCHF was given symptomatic treatment. Patient s polymerase chain reaction (PCR) assay was positive for CCHF virus. Patient was discharged after recovery. CCHF should be considered in differential diagnosis of patients between April to November in endemic areas.

Özet

Kırım-Kongo kanamalı ateşi (KKKA), kenelerle bulaşan, ateş ve kanamayla seyreden, akut ve ciddi seyirli olabilen viral zoonotik bir infeksiyon hastalığıdır. KKKA ülkemizin Orta ve Kuzey Anadolu Bölgelerinde endemik olarak görülmektedir. Hastalık genel olarak ilkbahar ve yaz aylarında görülmektedir. Bu yazı- da, Tokatta ilk defa Kasım ayında KKKA tanısı alan bir olgu sunulmuştur. Kene ısırığı sonrası halsizlik, yorgunluk, yaygın kas ağrıları ve yüksek ateş yakınmalarıyla başvuran 59 yaşındaki erkek hasta servise yatırılmıştır. Ateşi 39°C aksiller, kan basıncı 110/70 mmHg, nabzı 86/dakika olan hastanın fizik muayenesinde ateş dışında anlamlı bir bulgu yoktu. Laboratuvar incelemelerinde lökosit 2200/µL, hemoglobin 11.7 gr/dl, trombosit 78 000/ µL, C-reaktif protein 7.0 mg/dl, protrombin zamanı 14.7 saniye, aspartat transaminaz (AST) 63 İÜ/lt, alanin aminotransferaz (ALT) 42 İÜ/lt bulundu. Klinik ve laboratuvar bulgularına göre KKKA düşünülen hastaya semptomatik tedavi verildi. Hastanın KKKA polimeraz zincir reaksiyonu (PZR) testi pozitif bulundu. Genel durumu düzelen hasta şifayla taburcu edildi. Endemik bölgelerde Nisan-Kasım ayları arasında takip edilen hastalarda KKKAnın ayırıcı tanıda akılda tutulması gerektiğini düşünmekteyiz.

🔖

Cite This Article

DUYGU, F., TAVŞAN, Ö., KAYA, T. (2022). A Crimean-Congo Hemorrhagic Fever Case in an Endemic Region in November. Klimik Dergisi, Cilt: 25 - Sayı: 3, 130–132. https://ajindex.com/articles/573643

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006
  2. 6(4): 203-14. [CrossRef] 2. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004
  3. 64(3): 145-60. [CrossRef] 3. Ergönül Ö. Viral kanamalı ateşler. In: Willke Topçu A, Söyletir G, Doğanay M, eds. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. 3. baskı. İstanbul: Nobel Tıp Kitabevleri, 2008: 1251-65. 4. Ergönül O, Celikbaş A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004
  4. 39(2): 284-7. [CrossRef] 5. Karti SS, Odabasi Z, Korten V, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004
  5. 10(8): 1379-84. [CrossRef] 6. LeDuc JW. Epidemiology of hemorrhagic fever viruses. Rev Infect Dis. 1989
  6. 11(Suppl. 4): S730-5. [CrossRef] 7. Kara A. Kırım Kongo kanamalı ateşi. Türk Pediatri Arşivi. 2008
  7. 43(4): 108-18. 8. Ergönül Ö. Kırım-Kongo hemorajik ateşi: geçmiş ve gelecek. Klimik Derg. 2007
  8. 20(Suppl. 1): 163-7. 9. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H
  9. Turkish CCHF Study Group. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005
  10. 54(Pt 4): 385-9. [CrossRef] 10. Gubler DJ, Reiter P, Ebi KL, Yap W, Nasci R, Patz JA. Climate variability and change in the United States: potential impacts on vector- and rodent-borne diseases. Environ Health Perspect. 2001
  11. 109(Suppl. 2): 223-33. [CrossRef] 11. Lindgren E, Gustafson R. Tick-borne encephalitis in Sweden and climate change. Lancet. 2001
  12. 358(9275): 16-8. [CrossRef] 12. Estrada-Peña A. Forecasting habitat suitability for ticks and prevention of tick-borne diseases. Vet Parasitol. 2001
  13. 98(1-3): 111-32. [CrossRef] 13. Yilmaz GR, Buzgan T, Irmak H, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis. 2009
  14. 13(3): 380-6. [CrossRef] 14. Uluğ M. Kene ısırması nedeniyle başvuran olguların epidemiyolojik, klinik ve laboratuvar bulgularının irdelenmesi. Klimik Derg. 2011
  15. 24(1): 40-3. 15. Duygu F, Kaya T, Baysan P. Re-evaluation of 400 CrimeanCongo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable? Vector Borne Zoonotic Dis. 2012
  16. 12(9): 812-6. [CrossRef] 16. Köksal I, Yilmaz G, Iskender S, et al. The first Crimean-Congo hemorrhagic fever case in the winter season from Turkey. Intervirology. 2011